Stronger Sell Today ACAD ranks #5288 as SELL CANDIDATE #5288 Weaker Sell

ACAD stock forecast ACADIA Pharmaceuticals Inc.

ACAD stock forecast





ACAD Forecast and Technical Stock Analysis

Sell candidate since 2019-07-19

ACADIA Pharmaceuticals Inc. fell by -1.72% in the last day ( Friday, 19th Jul 2019 ) from $26.15 to $25.70 During day the stock fluctuated 2.19% from a day low at $25.54 to a day high of $26.10. The price has fallen in 7 of the last 10 days and is down by -5.31% for this period. Volume has increased in the last day by 0.36 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.13 million shares bought and sold for approximately $29.11 million.

Quick summary:

  • 30 day high of the ACAD stock price was $27.75 and low was $25.02.
  • 90 day high was $27.75 and low was $23.19.
  • 52 week high for the ACADIA Pharmaceuticals Inc. - $28.67 and low - $12.77.
Top Trending Stocks


ACADIA Pharmaceuticals Inc. lies in the lower part of a wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $25.03 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.47% during the next 3 months and, with 90% probability hold a price between $26.90 and $30.57 at the end of this period.

Top Golden Star Stocks


There are few to none technical positive signals at the moment. ACADIA Pharmaceuticals Inc. holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $26.41 and $26.02. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday July 18, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

A sell signal from a double bottom formation was found on Wednesday July 10, 2019 with a target of $26.61. Despite the objective of the signal formation has been reached the stock may continue to fall.

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 39 and the stock is currently not being overbought or oversold

* uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Support & Resistance

ACADIA Pharmaceuticals Inc. finds support from accumulated volume at $25.57.

Support: $25.57 Price: $25.70 Resistance: $25.93


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.56 (2.19%) between high and low. For the last week, the stock has had a daily average volatility of 3.19%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

3.19 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Strong Sell Candidate Downgraded


The ACADIA Pharmaceuticals Inc. stock holds several negative signals and despite the positive trend we believe ACADIA Pharmaceuticals Inc. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Sell Candidate.

Stronger Sell Today ACAD ranks #5288 as SELL CANDIDATE #5288 Weaker Sell

Will ACAD stock price go up or down on Mon, 22 Jul 2019?

Trading With Moving Average
As an investor, you always seek to understand what other... Full Article
Pivot Points
Pivot Points refer to points of significant change. As a... Full Article
Accumulated Volume - Support and Resistance
Volume is perhaps the best indicator of all and should... Full Article
Volume - The Indicator You Really Need to Know
Many new traders getting into the world of technical analysis... Full Article
We Give Back!
In 2016 donated to NGO Goodwill projects to help purchase medical... Full Article
Better Buy: Amazon vs. Facebook
Amazon's stock slipped 21% over the past six months, as... Full Article

Proudly made at